Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Using adaptive optics to assess hyporeflective clumps as a biomarker for progression to cRORA in the PINNACLE study
Author Affiliations & Notes
  • Christopher Holmes
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Naomi Wijesingha
    University College London, London, United Kingdom
  • Syed Ahmer Raza
    University College London, London, United Kingdom
  • Tom Taylor
    University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
  • Ahmed Hagag
    University College London, London, United Kingdom
  • Sophie Riedl
    Medizinische Universitat Wien, Wien, Wien, Austria
  • Julia Mai
    Medizinische Universitat Wien, Wien, Wien, Austria
  • Daniel Rueckert
    Imperial College London, London, London, United Kingdom
  • Hrvoje Bogunovic
    Medizinische Universitat Wien, Wien, Wien, Austria
  • Hendrik P Scholl
    Institute of Molecular and Clinical Ophthalmology Basel, Basel, Basel-Stadt, Switzerland
  • Ursula Schmidt-Erfurth
    Medizinische Universitat Wien, Wien, Wien, Austria
  • Lars Fritsche
    University of Michigan, Ann Arbor, Michigan, United States
  • Andrew Lotery
    University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
  • Sobha Sivaprasad
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Footnotes
    Commercial Relationships   Christopher Holmes None; Naomi Wijesingha None; Syed Ahmer Raza None; Tom Taylor None; Ahmed Hagag boehringer ingelheim, Code E (Employment); Sophie Riedl None; Julia Mai None; Daniel Rueckert IXICO Plc , Code I (Personal Financial Interest), IXICO Plc, Code O (Owner); Hrvoje Bogunovic Apellis, Heidelberg Engineering, Retinsight, Code F (Financial Support), Apellis, Bayer , Code R (Recipient); Hendrik Scholl Alnylam Pharmaceuticals Inc., Gerson Lehrman Group Inc., Guidepoint Global, LLC, Tenpoint Therapeutics, Code C (Consultant/Contractor), Boehringer Ingelheim Pharma GmbH & Co, Droia NV, Eluminex Biosciences, Gyroscope Therapeutics Ltd., Janssen Research & Development, LLC (Johnson & Johnson), Okuvision GmbH, ReVision Therapeutics Inc., Saliogen Therapeutics Inc, Code S (non-remunerative); Ursula Schmidt-Erfurth Topcon, Stealth BioTherapeutics, Novartis, Heidelberg Engineering, Boehringer Ingelheim, Aviceda, Apellis, Abbvie, Code C (Consultant/Contractor), Genentech, Kodiak, Novartis, Roche, RetinSight, Code F (Financial Support), RetinSight, Code P (Patent); Lars Fritsche None; Andrew Lotery Allergan , Apellis , Complement Therapeutics , Eyebio , Gyroscope/Novartis, Tarsus Pharmaceuticals, Code C (Consultant/Contractor); Sobha Sivaprasad AbbVie, Amgen, Apellis, Bayer, Biogen, Boehringer Ingelheim, Novartis, Eyebiotech, Eyepoint Phamaceuticals, Janssen Pharmaceuticals, Nova Nordisk, Optos, Ocular Therapeutix, Kriya Therapeutics, OcuTerra, Roche, Stealth Biotherapeutics and Sanofi. , Code F (Financial Support)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3264. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Christopher Holmes, Naomi Wijesingha, Syed Ahmer Raza, Tom Taylor, Ahmed Hagag, Sophie Riedl, Julia Mai, Daniel Rueckert, Hrvoje Bogunovic, Hendrik P Scholl, Ursula Schmidt-Erfurth, Lars Fritsche, Andrew Lotery, Sobha Sivaprasad; Using adaptive optics to assess hyporeflective clumps as a biomarker for progression to cRORA in the PINNACLE study. Invest. Ophthalmol. Vis. Sci. 2024;65(7):3264.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Adaptive optics ophthalmoscopy (AOO) provides high-resolution retinal imaging that allows visualization of hyporeflective clumps (HRC). HRCs are a highly dynamic finding in age-related macular degeneration (AMD) and are thought to correspond with melanin containing cells such as hyperreflective foci or retinal pigment epithelial (RPE) thickening on optical coherence tomography (OCT). Objective assessment of HRCs may confirm their role as a biomarker of disease progression in AMD and give mechanistic insights.

Methods : Eyes with intermediate AMD were divided into those that progressed to complete RPE and outer retinal atrophy (cRORA) on OCT, and those that had stable intermediate AMD for at least 12 months. All patients received imaging of the central 12° horizontally by 4° vertically with the rtx1 camera. Baseline AOO images were used in the “stable” group, and the latest images prior to cRORA detection were included in the “pre-cRORA” group. Montaged AOO images were processed with the Phansalkar method in ImageJ to objectively assess HRCs.

Results : Images were of adequate quality to assess HRCs in 48 eyes from 38 patients. Stable eyes (n=34) showed increased mean counts (p<0.005) and increased total (p<0.007) and percentage areas (p<0.005) of HRCs compared to pre-cRORA eyes (n=14) (fig 1). Mean HRC size appeared larger in pre-cRORA patients (143µm2) than stable patients (127µm2) but this did not reach statistical significance (p=0.13). In eyes with drusenoid pigment epithelial detachments, HRCs showed lower counts, (p=0.003), area (p=0.035) and percentage area (p=0.044) than eyes with large drusen (fig 2).

Conclusions : Eyes in the 12 months prior to cRORA development show significantly fewer HRCs, and the HRCs cover a smaller area compared to eyes with stable intermediate AMD. These differences likely reflect increased HRC clustering in pre-cRORA eyes, and HRC distribution may prove a valuable biomarker in AMD.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

Box whisker plots comparing HRC counts (a), total area (b), mean HRC size (c) and % area of image (d) between the pre-cRORA and stable groups.

Box whisker plots comparing HRC counts (a), total area (b), mean HRC size (c) and % area of image (d) between the pre-cRORA and stable groups.

 

Fig 2: Box whisker plots showing HRC counts (a), total area (b), mean HRC size (c) and % area of image (d) grouped by drusen subtype.

Fig 2: Box whisker plots showing HRC counts (a), total area (b), mean HRC size (c) and % area of image (d) grouped by drusen subtype.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×